Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomas.
Journal
Chemical science
ISSN: 2041-6520
Titre abrégé: Chem Sci
Pays: England
ID NLM: 101545951
Informations de publication
Date de publication:
18 Dec 2019
18 Dec 2019
Historique:
entrez:
14
6
2021
pubmed:
18
12
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Keratin 1 (KRT1) is overexpressed in squamous carcinomas and associated with aggressive pathologies in breast cancer. Herein we report the design and preparation of the first Trp-based red fluorogenic amino acid, which is synthetically accessible in a few steps and displays excellent photophysical properties, and its application in a minimally-disruptive labelling strategy to prepare a new fluorogenic cyclopeptide for imaging of KRT1+ cells in whole intact tumour tissues.
Identifiants
pubmed: 34123261
doi: 10.1039/c9sc05558d
pii: c9sc05558d
pmc: PMC8148049
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1368-1374Subventions
Organisme : European Research Council
ID : 771443
Pays : International
Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Chem Commun (Camb). 2012 Jul 28;48(59):7401-3
pubmed: 22715465
Angew Chem Int Ed Engl. 2019 Nov 18;58(47):16894-16898
pubmed: 31535788
J Am Chem Soc. 2016 Jan 13;138(1):402-7
pubmed: 26684612
J Biophotonics. 2012 Nov;5(11-12):815-26
pubmed: 23132668
Chem Commun (Camb). 2011 Oct 21;47(39):10939-41
pubmed: 21909540
J Am Chem Soc. 2018 Nov 21;140(46):15820-15826
pubmed: 30380856
Nature. 2011 Jun 08;475(7355):222-5
pubmed: 21654748
Oncogene. 2011 Jan 13;30(2):127-38
pubmed: 20890307
J Org Chem. 2013 Aug 16;78(16):8129-35
pubmed: 23865986
Histochem Cell Biol. 2008 Jun;129(6):705-33
pubmed: 18461349
Am J Med. 2013 Jun;126(6):472-9
pubmed: 23561631
Org Biomol Chem. 2016 Sep 26;14(38):8911-8921
pubmed: 27714204
Chem Sci. 2015 Feb 1;6(2):1150-1158
pubmed: 29560202
Chem Sci. 2019 Jun 21;10(29):6944-6956
pubmed: 31588261
Mol Pharm. 2017 Mar 6;14(3):593-604
pubmed: 28157321
J Med Chem. 2017 Jun 22;60(12):4893-4903
pubmed: 28520410
J Oncol. 2012;2012:438647
pubmed: 22848217
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Chem Commun (Camb). 2014 May 11;50(36):4714-6
pubmed: 24676233
Chem Sci. 2018 Nov 27;10(6):1619-1625
pubmed: 30842824
J Am Chem Soc. 2014 Dec 31;136(52):17942-5
pubmed: 25495860
J Med Chem. 2014 Oct 23;57(20):8530-9
pubmed: 25275946
Curr Opin Pharmacol. 2010 Oct;10(5):571-7
pubmed: 20598638
Front Oncol. 2017 Dec 22;7:314
pubmed: 29312886
Nat Rev Clin Oncol. 2016 Nov;13(11):674-690
pubmed: 27184417
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4317-22
pubmed: 20160097
Chem Commun (Camb). 2017 Jan 10;53(5):945-948
pubmed: 28009021
J Med Chem. 2009 Apr 23;52(8):2363-71
pubmed: 19296650
Bioconjug Chem. 2012 Dec 19;23(12):2434-43
pubmed: 23153224
J Org Chem. 2019 Mar 1;84(5):2879-2890
pubmed: 30726078
Chem Commun (Camb). 2009 Aug 14;(30):4515-7
pubmed: 19617968
Chem Sci. 2019 Aug 20;10(40):9351-9357
pubmed: 32110299
Nat Rev Cancer. 2005 Aug;5(8):591-602
pubmed: 16056258
Nat Commun. 2016 Mar 09;7:10940
pubmed: 26956772
Chemistry. 2009 Sep 21;15(37):9394-403
pubmed: 19575348
Arch Biochem Biophys. 2019 Jan;661:187-195
pubmed: 30465736
Nat Rev Immunol. 2015 Feb;15(2):73-86
pubmed: 25614318
Chem Soc Rev. 2015 Jul 21;44(14):4953-72
pubmed: 25801415
Chem Rev. 2012 Aug 8;112(8):4391-420
pubmed: 22616565
Chem Commun (Camb). 2011 Aug 7;47(29):8424-6
pubmed: 21701752
Angew Chem Int Ed Engl. 2017 Mar 27;56(14):3758-3769
pubmed: 27907246
Stem Cell Res. 2014 May;12(3):730-41
pubmed: 24727632
J Invest Dermatol. 2017 Jan;137(1):142-150
pubmed: 27595935
Nat Protoc. 2017 Aug;12(8):1588-1619
pubmed: 28703788
ACS Cent Sci. 2017 Sep 27;3(9):995-1005
pubmed: 28979941